Literature DB >> 23640483

4-Hydroxy-2-nonenal enhances tissue factor activity in human monocytic cells via p38 mitogen-activated protein kinase activation-dependent phosphatidylserine exposure.

Rit Vatsyayan1, Hema Kothari, Usha R Pendurthi, L Vijaya Mohan Rao.   

Abstract

OBJECTIVE: 4-hydroxy-2-nonenal (HNE) is one of the major aldehydes formed during lipid peroxidation and is believed to play a role in the pathogenesis of atherosclerosis. The objective of the present study is to investigate the effect of HNE on tissue factor (TF) procoagulant activity expressed on cell surfaces. APPROACH AND
RESULTS: TF activity and antigen levels on intact cells were measured using factor Xa generation and TF monoclonal antibody binding assays, respectively. Exposure of phosphatidylserine on the cell surface was analyzed using thrombin generation assay or by binding of a fluorescent dye-conjugated annexin V. 2',7'-dichlorodihydrofluorescein diacetate was used to detect the generation of reactive oxygen species. Our data showed that HNE increased the procoagulant activity of unperturbed THP-1 cells that express traces of TF antigen, but had no effect on unperturbed endothelial cells that express no measurable TF antigen. HNE increased TF procoagulant activity but not TF antigen of both activated monocytic and endothelial cells. HNE treatment generated reactive oxygen species, activated p38 mitogen-activated protein kinase, and increased the exposure of phosphatidylserine at the outer leaflet in THP-1 cells. Treatment of THP-1 cells with an antioxidant, N-acetyl cysteine, suppressed the above HNE-induced responses and negated the HNE-mediated increase in TF activity. Blockade of p38 mitogen-activated protein kinase activation inhibited HNE-induced phosphatidylserine exposure and increased TF activity.
CONCLUSIONS: HNE increases TF coagulant activity in monocytic cells through a novel mechanism involving p38 mitogen-activated protein kinase activation that leads to enhanced phosphatidylserine exposure at the cell surface.

Entities:  

Keywords:  4-hydroxy-2-nonenal; atherosclerosis; microparticles; oxidative stress; p38 mitogen-activated protein kinase; tissue factor

Mesh:

Substances:

Year:  2013        PMID: 23640483      PMCID: PMC3883589          DOI: 10.1161/ATVBAHA.113.300972

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  80 in total

1.  Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody.

Authors:  R A Fleck; L V Rao; S I Rapaport; N Varki
Journal:  Thromb Res       Date:  1990-07-15       Impact factor: 3.944

Review 2.  The role of lipid peroxidation and antioxidants in oxidative modification of LDL.

Authors:  H Esterbauer; J Gebicki; H Puhl; G Jürgens
Journal:  Free Radic Biol Med       Date:  1992-10       Impact factor: 7.376

3.  Oxidized low-density lipoprotein increases cultured human endothelial cell tissue factor activity and reduces protein C activation.

Authors:  J R Weis; R E Pitas; B D Wilson; G M Rodgers
Journal:  FASEB J       Date:  1991-07       Impact factor: 5.191

4.  Minimally oxidized low-density lipoprotein induces tissue factor expression in cultured human endothelial cells.

Authors:  T A Drake; K Hannani; H H Fei; S Lavi; J A Berliner
Journal:  Am J Pathol       Date:  1991-03       Impact factor: 4.307

5.  Oxidized LDL enhances lipopolysaccharide-induced tissue factor expression in human adherent monocytes.

Authors:  K Brand; C L Banka; N Mackman; R A Terkeltaub; S T Fan; L K Curtiss
Journal:  Arterioscler Thromb       Date:  1994-05

Review 6.  Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes.

Authors:  H Esterbauer; R J Schaur; H Zollner
Journal:  Free Radic Biol Med       Date:  1991       Impact factor: 7.376

7.  Immunostaining of human autopsy aortas with antibodies to modified apolipoprotein B and apoprotein(a).

Authors:  G Jürgens; Q Chen; H Esterbauer; S Mair; G Ledinski; H P Dinges
Journal:  Arterioscler Thromb       Date:  1993-11

Review 8.  Lipid peroxidation and its role in atherosclerosis.

Authors:  H Esterbauer; G Wäg; H Puhl
Journal:  Br Med Bull       Date:  1993-07       Impact factor: 4.291

9.  Polyunsaturated fatty acids reduce pyrogen-induced tissue factor expression in human monocytes.

Authors:  A Lalé; J M Herbert
Journal:  Biochem Pharmacol       Date:  1994-07-19       Impact factor: 5.858

10.  Enhanced tissue factor activity and plasminogen activator inhibitor-1 antigen in human umbilical vein endothelial cells incubated with lipoproteins.

Authors:  T Kaneko; H Wada; Y Wakita; K Minamikawa; T Nakase; Y Mori; K Deguchi; S Shirakawa
Journal:  Blood Coagul Fibrinolysis       Date:  1994-06       Impact factor: 1.276

View more
  16 in total

1.  The lipid peroxidation product 4-hydroxy-2-nonenal induces tissue factor decryption via ROS generation and the thioredoxin system.

Authors:  Shabbir A Ansari; Usha R Pendurthi; L Vijaya Mohan Rao
Journal:  Blood Adv       Date:  2017-11-27

2.  Type 1 interferon aggravates lipopolysaccharide-induced sepsis through upregulating Caspase-11 and Gasdermin D.

Authors:  Yan Wang; Xiaolei Zhang; Yujie Guo; Xiao Li; Guanyi Guo; Zhiyun Niu; Jingyu Zhang
Journal:  J Physiol Biochem       Date:  2021-01-30       Impact factor: 4.158

Review 3.  Involvement of 4-hydroxy-2-nonenal in the pathogenesis of pulmonary fibrosis.

Authors:  Edilburga Reyes-Jiménez; Alma Aurora Ramírez-Hernández; Jovito Cesar Santos-Álvarez; Juan Manuel Velázquez-Enríquez; Socorro Pina-Canseco; Rafael Baltiérrez-Hoyos; Verónica Rocío Vásquez-Garzón
Journal:  Mol Cell Biochem       Date:  2021-08-31       Impact factor: 3.396

4.  Chronic ethanol consumption decreases serum sulfatide levels by suppressing hepatic cerebroside sulfotransferase expression in mice.

Authors:  Hiroki Kanbe; Yuji Kamijo; Takero Nakajima; Naoki Tanaka; Eiko Sugiyama; Lixuan Wang; Zhong-Ze Fang; Atsushi Hara; Frank J Gonzalez; Toshifumi Aoyama
Journal:  Arch Toxicol       Date:  2013-09-25       Impact factor: 5.153

5.  PARP-14 combines with tristetraprolin in the selective posttranscriptional control of macrophage tissue factor expression.

Authors:  M Bilal Iqbal; Michael Johns; Jun Cao; Yu Liu; Sheng-Chun Yu; Gareth D Hyde; Michael A Laffan; Francesco P Marchese; Sung Hoon Cho; Andrew R Clark; Felicity N Gavins; Kevin J Woollard; Perry J Blackshear; Nigel Mackman; Jonathan L Dean; Mark Boothby; Dorian O Haskard
Journal:  Blood       Date:  2014-10-07       Impact factor: 22.113

6.  New Cellular Source of TF (Tissue Factor)-Positive Extracellular Vesicles in the Circulation.

Authors:  Silvio Antoniak; Nigel Mackman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-12-23       Impact factor: 8.311

Review 7.  Role of flavonoids in thrombotic, cardiovascular, and inflammatory diseases.

Authors:  Cijo George Vazhappilly; Shabbir Ahmed Ansari; Rula Al-Jaleeli; Aya Mudhafar Al-Azawi; Wafaa S Ramadan; Varsha Menon; Rawad Hodeify; Shoib Sarwar Siddiqui; Maxime Merheb; Rachel Matar; Rajan Radhakrishnan
Journal:  Inflammopharmacology       Date:  2019-07-15       Impact factor: 5.093

Review 8.  Redox regulation of genome stability by effects on gene expression, epigenetic pathways and DNA damage/repair.

Authors:  Yuliya Mikhed; Agnes Görlach; Ulla G Knaus; Andreas Daiber
Journal:  Redox Biol       Date:  2015-06-03       Impact factor: 11.799

9.  Foam cell-derived 4-hydroxynonenal induces endothelial cell senescence in a TXNIP-dependent manner.

Authors:  Yael Riahi; Nurit Kaiser; Guy Cohen; Ihab Abd-Elrahman; Galia Blum; Oz M Shapira; Tomer Koler; Maya Simionescu; Anca V Sima; Neven Zarkovic; Kamelija Zarkovic; Marica Orioli; Giancarlo Aldini; Erol Cerasi; Gil Leibowitz; Shlomo Sasson
Journal:  J Cell Mol Med       Date:  2015-03-05       Impact factor: 5.310

Review 10.  Redox-dependent thiol modifications: implications for the release of extracellular vesicles.

Authors:  Birke J Benedikter; Antje R Weseler; Emiel F M Wouters; Paul H M Savelkoul; Gernot G U Rohde; Frank R M Stassen
Journal:  Cell Mol Life Sci       Date:  2018-03-28       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.